1. Home
  2. HOPE vs NTLA Comparison

HOPE vs NTLA Comparison

Compare HOPE & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOPE
  • NTLA
  • Stock Information
  • Founded
  • HOPE 1986
  • NTLA 2014
  • Country
  • HOPE United States
  • NTLA United States
  • Employees
  • HOPE N/A
  • NTLA N/A
  • Industry
  • HOPE Major Banks
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • HOPE Finance
  • NTLA Health Care
  • Exchange
  • HOPE Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • HOPE 1.4B
  • NTLA 1.2B
  • IPO Year
  • HOPE 1996
  • NTLA 2016
  • Fundamental
  • Price
  • HOPE $10.88
  • NTLA $11.57
  • Analyst Decision
  • HOPE Buy
  • NTLA Buy
  • Analyst Count
  • HOPE 2
  • NTLA 20
  • Target Price
  • HOPE $13.25
  • NTLA $32.30
  • AVG Volume (30 Days)
  • HOPE 602.1K
  • NTLA 3.9M
  • Earning Date
  • HOPE 10-27-2025
  • NTLA 11-06-2025
  • Dividend Yield
  • HOPE 5.12%
  • NTLA N/A
  • EPS Growth
  • HOPE N/A
  • NTLA N/A
  • EPS
  • HOPE 0.34
  • NTLA N/A
  • Revenue
  • HOPE $412,692,000.00
  • NTLA $52,857,000.00
  • Revenue This Year
  • HOPE $17.88
  • NTLA $8.32
  • Revenue Next Year
  • HOPE $11.76
  • NTLA N/A
  • P/E Ratio
  • HOPE $32.12
  • NTLA N/A
  • Revenue Growth
  • HOPE N/A
  • NTLA 14.99
  • 52 Week Low
  • HOPE $8.83
  • NTLA $5.90
  • 52 Week High
  • HOPE $14.54
  • NTLA $23.76
  • Technical
  • Relative Strength Index (RSI)
  • HOPE 50.35
  • NTLA 52.67
  • Support Level
  • HOPE $10.97
  • NTLA $10.89
  • Resistance Level
  • HOPE $11.17
  • NTLA $12.03
  • Average True Range (ATR)
  • HOPE 0.20
  • NTLA 0.63
  • MACD
  • HOPE -0.02
  • NTLA 0.01
  • Stochastic Oscillator
  • HOPE 4.59
  • NTLA 43.49

About HOPE Hope Bancorp Inc.

Hope Bancorp Inc is a bank holding company engaged in providing financial services. It offers core business banking products for small and medium-sized businesses and individuals. Services offered by the bank include online banking, mobile banking, mortgage loans, credit cards, investment and wealth management services and other banking services.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: